Recursion Prices 61.54 Million Shares at $3.25 in Public Offering
Recursion Pharmaceuticals agreed to sell 61,540,000 Class A shares at $3.25 each, expecting about $200 million in gross proceeds before fees. Closing is targeted for Oct. 16, 2026, subject to customary conditions.
Recursion Pharmaceuticals entered into an Underwriting Agreement for a public offering of 61,540,000 shares of Class A common stock at $3.25 per share, all sold by the company. Gross proceeds are expected to be about $200 million before fees, with closing targeted for Oct 16, 2026, subject to custo…